Clinical Trial Update: Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluates repurposing an allergic rhinitis/allergic asthma medication to reduce vertigo and hearing loss in Menière's disease; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Menière Disease
• Vertigo

Snippet

Sponsor: House Ear Institute | Conditions: Meniere Disease, Allergic Rhinitis | Phase 4 | Status: ACTIVE_NOT_RECRUITING